Overview

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of Levobetaxolol in Chinese patients with glaucoma.
Phase:
Phase 3
Details
Lead Sponsor:
Lee's Pharmaceutical Limited
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Treatments:
Betaxolol
Ophthalmic Solutions
Tetrahydrozoline